Skip to main content
SpringerLink
Log in

Anticoagulant-related major bleeding costly in US

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2019 US dollars

Reference

  • Deitelzweig SB, et al. Evaluation of the Incremental Healthcare Economic Burden of Patients with Atrial Fibrillation Treated with Direct-Acting Oral Anticoagulants and Hospitalized for Major Bleeds in the USA. Advances in Therapy : 22 Jul 2020. Available from: URL: http://doi.org/10.1007/s12325-020-01440-9

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anticoagulant-related major bleeding costly in US. PharmacoEcon Outcomes News 859, 1 (2020). https://doi.org/10.1007/s40274-020-7010-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7010-3

Search

Navigation